Mifepristone Manufacturer Wins First Round in West Virginia
Drug & Device Law
MAY 19, 2023
In 2007 (during the Bush Administration), Congress amended the FDCA to provide for Risk Evaluation and Mitigation Strategy (“REMS”), “to assure safe use,” which the FDA applied to mifepristone. The potential customers were subject to a “credible threat” of prosecution.
111 
Let's personalize your content